126 related articles for article (PubMed ID: 18313151)
1. APOBEC and iNOS are not the main intracellular effectors of IFN-gamma-mediated inactivation of Hepatitis B virus replication.
Proto S; Taylor JA; Chokshi S; Navaratnam N; Naoumov NV
Antiviral Res; 2008 Jun; 78(3):260-7. PubMed ID: 18313151
[TBL] [Abstract][Full Text] [Related]
2. Induction of antiviral cytidine deaminases does not explain the inhibition of hepatitis B virus replication by interferons.
Jost S; Turelli P; Mangeat B; Protzer U; Trono D
J Virol; 2007 Oct; 81(19):10588-96. PubMed ID: 17652382
[TBL] [Abstract][Full Text] [Related]
3. N-terminal and C-terminal cytosine deaminase domain of APOBEC3G inhibit hepatitis B virus replication.
Lei YC; Tian YJ; Ding HH; Wang BJ; Yang Y; Hao YH; Zhao XP; Lu MJ; Gong FL; Yang DL
World J Gastroenterol; 2006 Dec; 12(46):7488-96. PubMed ID: 17167839
[TBL] [Abstract][Full Text] [Related]
4. Non-cytolytic inhibition of hepatitis B virus replication in human hepatocytes.
Suri D; Schilling R; Lopes AR; Mullerova I; Colucci G; Williams R; Naoumov NV
J Hepatol; 2001 Dec; 35(6):790-7. PubMed ID: 11738107
[TBL] [Abstract][Full Text] [Related]
5. Cytokine-sensitive replication of hepatitis B virus in immortalized mouse hepatocyte cultures.
Pasquetto V; Wieland SF; Uprichard SL; Tripodi M; Chisari FV
J Virol; 2002 Jun; 76(11):5646-53. PubMed ID: 11991993
[TBL] [Abstract][Full Text] [Related]
6. Role of ISGF3 in modulating the anti-hepatitis B virus activity of interferon-alpha in vitro.
Zhang Q; Wang Y; Wei L; Jiang D; Wang JH; Rao HY; Zhu L; Chen H; Fei R; Cong X
J Gastroenterol Hepatol; 2008 Nov; 23(11):1747-61. PubMed ID: 17559358
[TBL] [Abstract][Full Text] [Related]
7. Nitric oxide inhibits hepatitis B virus replication in the livers of transgenic mice.
Guidotti LG; McClary H; Loudis JM; Chisari FV
J Exp Med; 2000 Apr; 191(7):1247-52. PubMed ID: 10748242
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of hepatitis B virus DNA replicative intermediate forms by recombinant interferon-gamma.
Parvez MK; Sehgal D; Sarin SK; Basir SF; Jameel S
World J Gastroenterol; 2006 May; 12(19):3006-14. PubMed ID: 16718779
[TBL] [Abstract][Full Text] [Related]
9. Interferon inhibits hepatitis B virus replication in a stable expression system of transfected viral DNA.
Hayashi Y; Koike K
J Virol; 1989 Jul; 63(7):2936-40. PubMed ID: 2498531
[TBL] [Abstract][Full Text] [Related]
10. Mechanism of Enhanced HIV Restriction by Virion Coencapsidated Cytidine Deaminases APOBEC3F and APOBEC3G.
Ara A; Love RP; Follack TB; Ahmed KA; Adolph MB; Chelico L
J Virol; 2017 Feb; 91(3):. PubMed ID: 27881650
[TBL] [Abstract][Full Text] [Related]
11. Antiviral potential of interferon-omega on hepatitis B virus replication in human hepatoma cells.
Hagelstein J; Kist A; Stremmel W; Galle PR
Arzneimittelforschung; 1998 Mar; 48(3):343-7. PubMed ID: 9553691
[TBL] [Abstract][Full Text] [Related]
12. Interferon-regulated pathways that control hepatitis B virus replication in transgenic mice.
Guidotti LG; Morris A; Mendez H; Koch R; Silverman RH; Williams BR; Chisari FV
J Virol; 2002 Mar; 76(6):2617-21. PubMed ID: 11861827
[TBL] [Abstract][Full Text] [Related]
13. HBV Bypasses the Innate Immune Response and Does Not Protect HCV From Antiviral Activity of Interferon.
Mutz P; Metz P; Lempp FA; Bender S; Qu B; Schöneweis K; Seitz S; Tu T; Restuccia A; Frankish J; Dächert C; Schusser B; Koschny R; Polychronidis G; Schemmer P; Hoffmann K; Baumert TF; Binder M; Urban S; Bartenschlager R
Gastroenterology; 2018 May; 154(6):1791-1804.e22. PubMed ID: 29410097
[TBL] [Abstract][Full Text] [Related]
14. Development of a Novel Site-Specific Pegylated Interferon Beta for Antiviral Therapy of Chronic Hepatitis B Virus.
Tsuge M; Uchida T; Hiraga N; Kan H; Makokha GN; Abe-Chayama H; Miki D; Imamura M; Ochi H; Hayes CN; Shimozono R; Iwamura T; Narumi H; Suzuki T; Kainoh M; Taniguchi T; Chayama K
Antimicrob Agents Chemother; 2017 Jun; 61(6):. PubMed ID: 28373196
[TBL] [Abstract][Full Text] [Related]
15. Identification of type I and type II interferon-induced effectors controlling hepatitis C virus replication.
Metz P; Dazert E; Ruggieri A; Mazur J; Kaderali L; Kaul A; Zeuge U; Windisch MP; Trippler M; Lohmann V; Binder M; Frese M; Bartenschlager R
Hepatology; 2012 Dec; 56(6):2082-93. PubMed ID: 22711689
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-18 inhibits hepatitis B virus replication in the livers of transgenic mice.
Kimura K; Kakimi K; Wieland S; Guidotti LG; Chisari FV
J Virol; 2002 Nov; 76(21):10702-7. PubMed ID: 12368312
[TBL] [Abstract][Full Text] [Related]
17. Interferon-gamma, tumor necrosis factor-alpha, and interleukin 1-beta suppress the replication of hepatitis B virus through oxidative stress.
Togashi H; Ohno S; Matsuo T; Watanabe H; Saito T; Shinzawa H; Takahashi T
Res Commun Mol Pathol Pharmacol; 2000; 107(5-6):407-17. PubMed ID: 11589367
[TBL] [Abstract][Full Text] [Related]
18. Indoleamine 2,3-dioxygenase mediates the antiviral effect of gamma interferon against hepatitis B virus in human hepatocyte-derived cells.
Mao R; Zhang J; Jiang D; Cai D; Levy JM; Cuconati A; Block TM; Guo JT; Guo H
J Virol; 2011 Jan; 85(2):1048-57. PubMed ID: 21084489
[TBL] [Abstract][Full Text] [Related]
19. Type I interferons inhibit hepatitis B virus replication and induce hepatocellular gene expression in cultured liver cells.
Caselmann WH; Meyer M; Scholz S; Hofschneider PH; Koshy R
J Infect Dis; 1992 Nov; 166(5):966-71. PubMed ID: 1328410
[TBL] [Abstract][Full Text] [Related]
20. Interferon-inducible expression of APOBEC3 editing enzymes in human hepatocytes and inhibition of hepatitis B virus replication.
Bonvin M; Achermann F; Greeve I; Stroka D; Keogh A; Inderbitzin D; Candinas D; Sommer P; Wain-Hobson S; Vartanian JP; Greeve J
Hepatology; 2006 Jun; 43(6):1364-74. PubMed ID: 16729314
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]